TRPV1 and inflammatory bowel disease: Novel anti-inflammatory effects of TRPV1 in LPS-induced sepsis are also highlighted, wherein human models of TNBS- and DSS-induced colitis and IBD report predominantly pro-inflammatory characteristics of this channel.